Study Evaluating Single Doses of ILV-095 in Healthy Japanese Male Subjects

NCT00822484 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Subjects

Interventions

BIOLOGICAL: ILV-095
OTHER: Placebo

Sponsor

Wyeth is now a wholly owned subsidiary of Pfizer